Overview

We at BioNTech believe that adhering to the highest Corporate Governance standards positively impacts our performance and we put great importance on building trust with investors, the public and other stakeholders. We are committed to transparency of corporate communication and cooperation between our Management and Supervisory Board aimed at increasing shareholder value over the long term.

Committee Composition

Below is a summary of our committee structure and membership information. To read more about any of the committees, click on committee names in the chart below.

 = Chairperson  = Member = Financial Expert for Audit Committee
Audit Committee Capital Markets Committee Compensation, Nominating and Corporate Governance Committee Product Committee
Helmut Jeggle Capital Markets Committee Product Committee
Dr. Ulrich Wandschneider Audit Committee Product Committee
Michael Motschmann Capital Markets Committee Compensation, Nominating and Corporate Governance Committee
Prof. Dr. Anja Morawietz Audit Committee Capital Markets Committee
Prof. Dr. Rudolf Staudigl Audit Committee Compensation, Nominating and Corporate Governance Committee
Baroness Nicola Blackwood Compensation, Nominating and Corporate Governance Committee Product Committee
= Chairperson = Member = Financial Expert

Board Diversity Matrix 2024

Board Diversity Matrix 2023

Show all

Corporate Governance Documents

Show all

2020

Show all

2020

Show all
Show all

2022

Show all

2023

CSR Documents

Show all
Show all

Compliance

Show all

Whistleblower Hotline
BioNTech Hotline (anonymous)
Online Access to Whistle Blowing Reporting
Or by Email

BioNTech SE

An der Goldgrube 12

55131 Mainz, Germany

T: +49 6131 9084-0

F: +49 6131 9084-2121

service@biontech.de

© 2026  BioNTech
All rights reserved